Inmunización y respuesta inmune a la vacuna neumocócica / Immunization and immune response to neumococcal vaccine

RESUMO

The aim of this work was to define antibody levels against four neumococcal serotypes, before and after neumococcal vaccination in patients with respiratory infections. Fifty one patients were studied, 19 children from 1 to 5 yeras old, 19 children from 6 to 18 years old and 22 adults from 27 to 65 years old. IgG anti-neumococcal, antibodies, against serotypes 3, 7F, 9N and 14 were measured using an enzyme immunoassay, before and four weeks after vaccination. There was a significant increase in antibody titers against all serotypes in subjects older 7 yeras. In children of less than 6 yeras, the response to serotype 14 was non significant. The intensity of response differed according to the studied serotypes and the percentage of patients that responded to each serotype increased with age. Five patients older than 18 years were identified as non responders to all four serotypes. It is concluded that neumococcal vaccine increases anti-neumococcal antibodies in patients with recurrent infections and allows the identification of patients with specific antibody deficiency syndromes and normal total immunoglobulin levels